HEALTHSTREAM INC
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
HSTM$28.85-0.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. *Financial Statements*
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
| September 30, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $53,544 | $59,469 |
| Marketable securities | 39,047 | 37,748 |
| Accounts receivable, net | 27,675 | 30,189 |
| Accounts receivable - unbilled | 6,047 | 5,133 |
| Prepaid and other current assets | 21,261 | 20,583 |
| Total current assets | 147,574 | 153,122 |
| Property and equipment, net | 11,143 | 10,741 |
| Capitalized software development, net | 45,699 | 43,370 |
| Operating lease right of use assets, net | 15,667 | 17,453 |
| Goodwill | 191,623 | 191,220 |
| Intangibles, net | 45,369 | 55,548 |
| Other assets | 42,855 | 39,312 |
| Total assets | $499,930 | $510,766 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $3,924 | $6,628 |
| Accrued royalties | 5,642 | 5,190 |
| Accrued liabilities | 10,643 | 10,141 |
| Accrued compensation | 6,600 | 9,507 |
| Deferred revenue | 85,687 | 84,227 |
| Total current liabilities | 112,496 | 115,693 |
| Deferred tax liabilities | 19,671 | 14,596 |
| Deferred revenue, noncurrent | 1,289 | 1,655 |
| Operating lease liability, noncurrent | 15,292 | 17,366 |
| Other long-term liabilities | 1,989 | 2,101 |
| Commitments and contingencies | ||
| Shareholders’ equity: | ||
| Preferred Stock, no par value, 10,000 shares authorized, no shares issued or outstanding | — | — |
| Common stock, no par value, 75,000 shares authorized; 29,652 and 30,432 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | 228,753 | 252,432 |
| Retained earnings | 121,972 | 108,972 |
| Accumulated other comprehensive loss | (1,532) | (2,049) |
| Total shareholders’ equity | 349,193 | 359,355 |
| Total liabilities and shareholders’ equity | $499,930 | $510,766 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.